CN Patent

CN118785905A — 使用t-型钙通道调节剂的治疗方法

Assigned to Praxis Precision Pharmaceuticals · Expires 2024-10-15 · 2y expired

What this patent protects

本文部分地描述了用于在有此需要的受试者中治疗与T‑型钙通道的异常功能或活性有关的疾病或病症如特发性震颤的方法，所述方法包括与普萘洛尔、扑米酮、托吡酯或其药学上可接受的盐中的至少一种组合地施用T‑型钙通道抑制剂。本文还公开了包含T‑型钙通道抑制剂和普萘洛尔、扑米酮、托吡酯或其药学上可接受的盐中的至少一种的组合物。

USPTO Abstract

本文部分地描述了用于在有此需要的受试者中治疗与T‑型钙通道的异常功能或活性有关的疾病或病症如特发性震颤的方法，所述方法包括与普萘洛尔、扑米酮、托吡酯或其药学上可接受的盐中的至少一种组合地施用T‑型钙通道抑制剂。本文还公开了包含T‑型钙通道抑制剂和普萘洛尔、扑米酮、托吡酯或其药学上可接受的盐中的至少一种的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN118785905A
Jurisdiction
CN
Classification
—
Expires
2024-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Praxis Precision Pharmaceuticals
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.